NDC 43772-0038

Lymesode

Echinacea (angustifolia), Hydrastis Canadensis, Lycopodium Clavatum, Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Rhus Tox, Arnica Montana, Glandula Suprarenalis Suis, Medulla Ossis Suis, Thymus (suis), Oxalicum Acidum, Magnesia Phosphorica, Latrodectus Mactans, Borrelia Burgdorferi Nosode, Encephalitis Nosode, Meningococcus Nosode, Hepatitis B Nosode

Lymesode is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Synergy Formulas, Inc.. The primary component is Echinacea Angustifolia; Goldenseal; Lycopodium Clavatum Spore; Nasturtium Officinale; Taraxacum Officinale; Trifolium Pratense Flower; Toxicodendron Pubescens Leaf; Arnica Montana; Sus Scrofa Adrenal Gland; Sus Scrofa Bone Marrow; Sus Scrofa Thymus; Oxalic Acid; Magnesium Phosphate, Dibasic Trihydrate; Latrodectus Mactans; Borrelia Burgdorferi; Japanese Encephalitis Virus; Neisseria Meningitidis; Hepatitis B Virus.

Product ID43772-0038_4b58c4de-2677-4791-ac10-a3119fe7923b
NDC43772-0038
Product TypeHuman Otc Drug
Proprietary NameLymesode
Generic NameEchinacea (angustifolia), Hydrastis Canadensis, Lycopodium Clavatum, Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Rhus Tox, Arnica Montana, Glandula Suprarenalis Suis, Medulla Ossis Suis, Thymus (suis), Oxalicum Acidum, Magnesia Phosphorica, Latrodectus Mactans, Borrelia Burgdorferi Nosode, Encephalitis Nosode, Meningococcus Nosode, Hepatitis B Nosode
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2014-07-15
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameSynergy Formulas, Inc.
Substance NameECHINACEA ANGUSTIFOLIA; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; NASTURTIUM OFFICINALE; TARAXACUM OFFICINALE; TRIFOLIUM PRATENSE FLOWER; TOXICODENDRON PUBESCENS LEAF; ARNICA MONTANA; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA THYMUS; OXALIC ACID; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; LATRODECTUS MACTANS; BORRELIA BURGDORFERI; JAPANESE ENCEPHALITIS VIRUS; NEISSERIA MENINGITIDIS; HEPATITIS B VIRUS
Active Ingredient Strength3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 43772-0038-1

60 mL in 1 BOTTLE, DROPPER (43772-0038-1)
Marketing Start Date2014-07-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43772-0038-1 [43772003801]

Lymesode LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-07-15
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
ECHINACEA ANGUSTIFOLIA3 [hp_X]/mL

OpenFDA Data

SPL SET ID:09c53a0d-c655-40f6-9419-d27b17e2989d
Manufacturer
UNII

NDC Crossover Matching brand name "Lymesode" or generic name "Echinacea (angustifolia), Hydrastis Canadensis, Lycopodium Clavatum, Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Rhus Tox, Arnica Montana, Glandula Suprarenalis Suis, Medulla Ossis Suis, Thymus (suis), Oxalicum Acidum, Magnesia Phosphorica, Latrodectus Mactans, Borrelia Burgdorferi Nosode, Encephalitis Nosode, Meningococcus Nosode, Hepatitis B Nosode"

NDCBrand NameGeneric Name
43772-0021LymesodeChelidonium majus, Echinacea (Angustifolia), Hydrastis canadensis, Nasturtium aquaticum, Taraxacum officinale, Trifolium pratense, Rhus toxicodendron, Arnica montana,
43772-0038LymesodeEchinacea (Angustifolia), Hydrastis Canadensis, Lycopodium Clavatum, Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Rhus Tox, Arnica Montana, Glandula Suprarenalis Suis, Medulla Ossis Suis, Thymus (Suis), Oxalicum Acidum, Magnesia Phosphorica, Latrodectus Mactans, Borrelia Burgdorferi Nosode, Encephalitis Nosode, Meningococcus Nosode, Hepatitis B Nosode

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.